Friday, April 04, 2008

Psychiatric News article on CME and pharma influence

An excerpt:
Intensifying criticism from academia, the media, and regulators has been directed at perceived bias in the large proportion of CME content that often favors a newly marketed product or off-label use of a product manufactured by the sponsor. The Senate report is primarily concerned about such influence on drug expenditures for Medicare and Medicaid.
Click here to read the article.

No comments: